Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.
Rakha EA, Quinn C, Raymond W, Allison KH, Badve SS, Brogi E, Callagy G, Charafe-Jauffret E, Chen CJ, Chen YY, Collins LC, Cserni G, Djerroudi L, Jaffer S, Foschini MP, Gobbi H, Gudi M, Harada O, Kulka J, Kuroda H, Lakhani SR, Li X, Moriya T, O'Toole SA, Pinder SE, Provenzano E, Sahin AA, Schmitt F, Shaaban AM, Siziopikou KP, Tang P, Tse GM, Varga Z, Vincent-Salomon A, Wen H, Yamaguchi R, Yang W, Fox SB, Schnitt SJ, Ellis IO, Tan PH.
Mod Pathol. 2025 May;38(5):100734. doi: 10.1016/j.modpat.2025.100734. Epub 2025 Feb 11.
Precision pathology as applied to breast core needle biopsy evaluation: implications for management.
Collins LC.
Mod Pathol. 2021 Jan;34(Suppl 1):48-61. doi: 10.1038/s41379-020-00666-w. Epub 2020 Sep 2.
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z.
Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17.
Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature.
Kalvala J, Parks RM, Green AR, Cheung KL.
Histopathology. 2022 Feb;80(3):468-484. doi: 10.1111/his.14555. Epub 2021 Oct 13.
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
Rubio IT, Wyld L, Marotti L, Athanasiou A, Regitnig P, Catanuto G, Schoones JW, Zambon M, Camps J, Santini D, Dietz J, Sardanelli F, Varga Z, Smidt M, Sharma N, Shaaban AM, Gilbert F.
Eur J Surg Oncol. 2024 Jan;50(1):107292. doi: 10.1016/j.ejso.2023.107292. Epub 2023 Nov 27.
Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-Analysis.
Shehata MN, Rahbar H, Flanagan MR, Kilgore MR, Lee CI, Ryser MD, Lowry KP.
J Am Coll Radiol. 2020 Oct;17(10):1207-1219. doi: 10.1016/j.jacr.2020.07.036. Epub 2020 Aug 27.
Apocrine lesions of the breast.
Quinn CM, D'Arcy C, Wells C.
Virchows Arch. 2022 Jan;480(1):177-189. doi: 10.1007/s00428-021-03185-4. Epub 2021 Sep 18.
Low-Cost Vacuum Assisted Core Needle Biopsy Technique for Breast Lumps.
Yadav SK, Carpenter A, Rai R, Jha CK, Sharma D.
World J Surg. 2022 Jun;46(6):1445-1450. doi: 10.1007/s00268-022-06475-3. Epub 2022 Feb 15.
High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision.
Harbhajanka A, Gilmore HL, Calhoun BC.
Mod Pathol. 2022 Nov;35(11):1500-1508. doi: 10.1038/s41379-022-01092-w. Epub 2022 Jun 2.
Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature.
Calhoun BC, Collins LC.
Histopathology. 2016 Jan;68(1):138-51. doi: 10.1111/his.12852.
